259 related articles for article (PubMed ID: 25432985)
1. PDE2 activity differs in right and left rat ventricular myocardium and differentially regulates β2 adrenoceptor-mediated effects.
Soler F; Fernández-Belda F; Pérez-Schindler J; Handschin C; Fuente T; Hernandez-Cascales J
Exp Biol Med (Maywood); 2015 Sep; 240(9):1205-13. PubMed ID: 25432985
[TBL] [Abstract][Full Text] [Related]
2. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat.
Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J
Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterases inhibition unmask a positive inotropic effect mediated by beta2-adrenoceptors in rat ventricular myocardium.
Gonzalez-Muñoz C; Fuente T; Hernández-Cascales J
Eur J Pharmacol; 2009 Apr; 607(1-3):151-5. PubMed ID: 19239906
[TBL] [Abstract][Full Text] [Related]
4. The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
Juan-Fita MJ; Vargas ML; Hernández J
Eur J Pharmacol; 2005 Apr; 512(2-3):207-13. PubMed ID: 15840406
[TBL] [Abstract][Full Text] [Related]
5. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium.
Carceles MD; Fuentes T; Aroca V; Lopez J; Hernández J
Clin Ther; 2007 Aug; 29(8):1718-24. PubMed ID: 17919552
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase PDE2 activity, increased by isoprenaline, does not reduce β-adrenoceptor-mediated chronotropic and inotropic effects in rat heart.
Galindo-Tovar A; Vargas ML; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jun; 391(6):571-585. PubMed ID: 29556684
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
9. The increase in rat ventricular automaticity induced by salbutamol is mediated through β(1)- but not β(2)-adrenoceptors: role of phosphodiesterases.
Gonzalez-Muñoz C; Fuente T; Medin-Aguerre S; Hernández-Cascales J
Life Sci; 2011 Jun; 88(25-26):1095-101. PubMed ID: 21565204
[TBL] [Abstract][Full Text] [Related]
10. Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.
Bastug-Özel Z; Wright PT; Kraft AE; Pavlovic D; Howie J; Froese A; Fuller W; Gorelik J; Shattock MJ; Nikolaev VO
Cardiovasc Res; 2019 Mar; 115(3):546-555. PubMed ID: 30165515
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
[TBL] [Abstract][Full Text] [Related]
12. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
Zhao CY; Greenstein JL; Winslow RL
J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of phosphodiesterases PDE2, PDE3, and PDE4 do not increase the sinoatrial tachycardia of noradrenaline and prostaglandin PGE₁ in mice.
Galindo-Tovar A; Vargas ML; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):177-86. PubMed ID: 26531832
[TBL] [Abstract][Full Text] [Related]
15. Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.
Pönicke K; Gröner F; Heinroth-Hoffmann I; Brodde OE
Br J Pharmacol; 2006 Apr; 147(7):714-9. PubMed ID: 16474418
[TBL] [Abstract][Full Text] [Related]
16. Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells.
Oehme S; Mittag A; Schrödl W; Tarnok A; Nieber K; Abraham G
Pulm Pharmacol Ther; 2015 Feb; 30():110-20. PubMed ID: 24915152
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
Galindo-Tovar A; Kaumann AJ
Br J Pharmacol; 2008 Feb; 153(4):710-20. PubMed ID: 18084319
[TBL] [Abstract][Full Text] [Related]
19. Functional beta1- and beta2-adrenoceptors in the left and right atrium of pre-hypertensive rats.
Doggrell SA
J Pharm Pharmacol; 2002 Oct; 54(10):1407-12. PubMed ID: 12396304
[TBL] [Abstract][Full Text] [Related]
20. Diazepam potentiates the effects of endogenous catecholamines on contractility and cyclic AMP levels in rat ventricular myocardium.
Marín J; Hernández J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):260-8. PubMed ID: 11919649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]